Meet Our Team
Innovates To Heal, To Balance and To Correct
SANARE BIOSCIENCE SERVICES strives to improve medications and outcomes for patients. Our team is integral in achieving this goal.
Jack Donaldson IV M.Ed,
President, Founder
Dr Melissa Clarke
CMO
Dan Blue, Executive Counsel
Dr. Valerie Armstead
CRO
Gustavo Moura Letts, Phd
John McAdory
VP of Clinical Trials
Advisory Board
Dr. Winston Parris Professor Emeritus
Candis Edwards
Andre Harrell
Kavan Clifford MD, Phd
Richard Manson
Jack Donaldson IV M.Ed President & Founder
Jack Donaldson IV, Founder, President of Sanare Bioscience has worked 14-years as a healthcare consultant and Innovator. He has worked with healthcare providers, manufacturers, distributors and hospital group purchasing organizations. Jack has built a network of over 300 physicians and 400 independent pharmacies. Jack's always been a patient advocate building value and educating in the healthcare supply chain
Dr Melissa Clarke CMO
Harvard-trained, Dr. Clarke is an Emergency Medicine (EM) physician with deep clinical, academic and private sector healthcare experience. A former Assistant Dean at her institution, she led the EM research program and served for 10 years on the Institutional Review Board. [She has served on NIH advisory boards, and published on pharmacogenomics in clinical practice.] In the private sector, she [leads healthcare system transformation work, and] has served as a Senior Medical Director in the insurance industry and VP of Population Health for an integrated clinical network serving addiction patients.
Dan Blue, Executive Counsel
Dan Blue, Legal Counsel • Executive Director of the Pharmaceutical Institute • Founder Campbell Alliance, a biopharma industry consultancy • Healthcare banker with Bear, Stearns & Co. • J.D., Duke Law School, M.B.A., Duke University Fuqua School of Business, B.S.E., Duke University
Dr. Valerie Armstead, CRO
Dr. Armstead has over 30 years of experience in pediatric, cardiovascular & thoracic anesthesiology. Dr. Armstead remains active in medical & health education, clinical trials, translational research and has served as chief medical officer (CMO) or on advisory boards for a number of companies. She currently is a Professor of Anesthesiology at Temple University Health System
Andrell Harrell, Chief Commercial Officer
Dr. Armstead has over 30 years of experience in pediatric, cardiovascular & thoracic anesthesiology. Dr. Armstead remains active in medical & health education, clinical trials, translational research and has served as chief medical officer (CMO) or on advisory boards for a number of companies. She currently is a Professor of Anesthesiology at Temple University Health System
John McAdory, VP of Clinical Trials
John has over 20 years of experience in global clinical development from clinical study design to final study report, in all phases (phases 1 to 3) of clinical programs through NDA/MAA filing (phase 3). Expertise in all aspects of clinical operations project management including oversight of CROs and external service providers.
Dr. Winston Parris Professor Emeritus, Advisory Board Member
Dr. Winston Parris is a world-renowned pain management specialist and professor Emeritus with 50+ years of medical & research experience. Dr Parris will be advising Sanare Bioscience with research and product development.
Candis Edwards, Advisory Board Member
Candis Edwards has forty years of experience working in regulatory affairs and clinical trials for drug development, both domestically and internationally.
Gustavo Moura-Letts
​
Gustavo leads a team of scientists as an experienced organic chemist focused on drug design and medicinal chemistry
Kavan Clifford MD Phd, Advisory Board Member
Dr Kavan Clifford graduated from Medical School, Residency and Fellowship from John Hopkins University School of Medicine. Dr Clifford has been practicing Anesthesiology for 10 years and will support Sanare Bioscience with strategic relationships and clinical support.
Richard Manson
Richard Manson is a premier provider of innovative products, services and solutions to the health-care and retail pharmacy industry.